PFS
IBRX icon

Prospera Financial Services’s ImmunityBio IBRX Stock Holding History

Prospera Financial Services’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Buy
+12,460
New +$94.3K ﹤0.01% 1434
2022
Q2 		– Sell
-1,559
Closed -$9K – 2074
2022
Q1 		$9K Buy
+1,559
New +$9.56K ﹤0.01% 2079

Other funds holding IBRX

SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MWM
MFG Wealth Management Indianapolis, Indiana $140M AUM 44.72% 1-Year Est. Return
DKCM
Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CFO
Collective Family Office York, Pennsylvania $489M AUM 21.64% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
CIC
Cutler Investment Counsel Jacksonville, Oregon $1.06B AUM 20.29% 1-Year Est. Return

Prospera Financial Services's IBRX Position: Q2 2026 in Review

Prospera Financial Services opened a new position in ImmunityBio (IBRX) in Q2 2026: 12,460 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #1434 among its holdings. This is a return to the name: Prospera Financial Services previously reported a position in IBRX as recently as Q1 2022.

Prospera Financial Services first reported a position in IBRX in Q1 2022 and has held it in 2 quarters since. 48 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Prospera Financial Services held 12,460 shares of ImmunityBio worth $109K as of Q2 2026.
  • ImmunityBio was a new Prospera Financial Services position in Q2 2026.
  • ImmunityBio made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1434 holding.
  • Prospera Financial Services first reported a position in ImmunityBio in Q1 2022 and has held it in 2 quarters since.
  • 48 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.